Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.

Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y.

Stem Cells Transl Med. 2012 Jun;1(6):451-61. doi: 10.5966/sctm.2011-0044. Epub 2012 May 30.

2.

Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.

Ye L, Muench MO, Fusaki N, Beyer AI, Wang J, Qi Z, Yu J, Kan YW.

Stem Cells Transl Med. 2013 Aug;2(8):558-66. doi: 10.5966/sctm.2013-0006. Epub 2013 Jul 11.

3.

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.

Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S.

Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14234-9. doi: 10.1073/pnas.1103509108. Epub 2011 Aug 5.

4.

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Phang RZ, Tay FC, Goh SL, Lau CH, Zhu H, Tan WK, Liang Q, Chen C, Du S, Li Z, Tay JC, Wu C, Zeng J, Fan W, Toh HC, Wang S.

Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

5.

Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.

Jin ZB, Okamoto S, Xiang P, Takahashi M.

Stem Cells Transl Med. 2012 Jun;1(6):503-9. doi: 10.5966/sctm.2012-0005. Epub 2012 Jun 1.

6.

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.

Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y.

Stem Cell Res Ther. 2011 Nov 16;2(6):46. doi: 10.1186/scrt87.

7.

Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.

Zhou H, Martinez H, Sun B, Li A, Zimmer M, Katsanis N, Davis EE, Kurtzberg J, Lipnick S, Noggle S, Rao M, Chang S.

Stem Cell Rev. 2015 Aug;11(4):652-65. doi: 10.1007/s12015-015-9586-8.

8.

Generation of human induced pluripotent stem cells bearing an anti-HIV transgene by a lentiviral vector carrying an internal murine leukemia virus promoter.

Kamata M, Liu S, Liang M, Nagaoka Y, Chen IS.

Hum Gene Ther. 2010 Nov;21(11):1555-67. doi: 10.1089/hum.2010.050. Epub 2010 Oct 6.

9.

Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector.

Ono M, Hamada Y, Horiuchi Y, Matsuo-Takasaki M, Imoto Y, Satomi K, Arinami T, Hasegawa M, Fujioka T, Nakamura Y, Noguchi E.

PLoS One. 2012;7(8):e42855. doi: 10.1371/journal.pone.0042855. Epub 2012 Aug 13.

10.

Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.

Tucker BA, Anfinson KR, Mullins RF, Stone EM, Young MJ.

Stem Cells Transl Med. 2013 Jan;2(1):16-24. doi: 10.5966/sctm.2012-0040. Epub 2012 Dec 27.

11.

Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.

Varga E, Nemes C, Davis RP, Ujhelly O, Klincumhom N, Polgar Z, Muenthaisong S, Pirity MK, Dinnyes A.

Exp Cell Res. 2014 Apr 1;322(2):335-44. doi: 10.1016/j.yexcr.2014.02.006. Epub 2014 Feb 18.

PMID:
24560743
12.
13.

Generation of human induced pluripotent stem cells from peripheral blood using the STEMCCA lentiviral vector.

Sommer AG, Rozelle SS, Sullivan S, Mills JA, Park SM, Smith BW, Iyer AM, French DL, Kotton DN, Gadue P, Murphy GJ, Mostoslavsky G.

J Vis Exp. 2012 Oct 31;(68). pii: 4327. doi: 10.3791/4327.

14.

Excision of viral reprogramming cassettes by Cre protein transduction enables rapid, robust and efficient derivation of transgene-free human induced pluripotent stem cells.

Kadari A, Lu M, Li M, Sekaran T, Thummer RP, Guyette N, Chu V, Edenhofer F.

Stem Cell Res Ther. 2014 Apr 8;5(2):47. doi: 10.1186/scrt435.

15.

Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

Meng X, Neises A, Su RJ, Payne KJ, Ritter L, Gridley DS, Wang J, Sheng M, Lau KH, Baylink DJ, Zhang XB.

Mol Ther. 2012 Feb;20(2):408-16. doi: 10.1038/mt.2011.258. Epub 2011 Nov 22.

16.

A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.

Lu HF, Chai C, Lim TC, Leong MF, Lim JK, Gao S, Lim KL, Wan AC.

Biomaterials. 2014 Mar;35(9):2816-26. doi: 10.1016/j.biomaterials.2013.12.050. Epub 2014 Jan 9.

PMID:
24411336
17.

Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.

Eggenschwiler R, Loya K, Wu G, Sharma AD, Sgodda M, Zychlinski D, Herr C, Steinemann D, Teckman J, Bals R, Ott M, Schambach A, Schöler HR, Cantz T.

Stem Cells Transl Med. 2013 Sep;2(9):641-54. doi: 10.5966/sctm.2013-0017. Epub 2013 Aug 7.

18.

New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood.

Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, Ban H, Hasegawa M, Yamashita S, Kimura S, Suzuki S, Matsuzawa T, Akari H, Era T.

PLoS One. 2014 Dec 5;9(12):e113052. doi: 10.1371/journal.pone.0113052. eCollection 2014.

19.

Simple derivation of transgene-free iPS cells by a dual recombinase approach.

Pertek A, Meier F, Irmler M, Beckers J, Skylaki S, Endele M, Wurst W, Prakash N, Kühn R.

Mol Biotechnol. 2014 Aug;56(8):697-713. doi: 10.1007/s12033-014-9748-y.

PMID:
24677035
20.

Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.

Papapetrou EP, Sadelain M.

Nat Protoc. 2011 Aug 4;6(9):1251-73. doi: 10.1038/nprot.2011.374.

PMID:
21886095
Items per page

Supplemental Content

Write to the Help Desk